TolerogenixX GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tolerogenixx.com
Clinical Trials
3
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
Phase 2
Recruiting
- Conditions
- Kidney Transplantation
- Interventions
- Other: Standard of Care
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- TolerogenixX GmbH
- Target Recruit Count
- 126
- Registration Number
- NCT05365672
- Locations
- 🇩🇪
Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin Charité - Universitätsmedizin Berlin, Berlin, Germany
🇩🇪Universitätsklinikum Hamburg-Eppendorf, Universitäres Transplantations Centrum, Hamburg, Germany
🇩🇪Medizinische Klinik, Innere Medizin X Nephrologie - Nierenzentrum Universitätsklinikum Heidelberg, Heidelberg, Germany
News
No news found